K. Max Broden's most recent trade in Trupanion Inc was a trade of 6,375 Restricted Stock Unit (RSU) done . Disclosure was reported to the exchange on May 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Trupanion Inc | Max K. Broden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2026 | 6,375 | 6,375 | - | - | Restricted Stock Unit (RSU) | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 49,458 | 169,230 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.20 per share. | 10 Feb 2026 | 21,854 | 147,376 (0%) | 0% | 113.2 | 2,473,873 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 65 | 405 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.30 per share. | 10 Feb 2026 | 10 | 395 (0%) | 0% | 116.3 | 1,163 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.20 per share. | 09 Feb 2026 | 2,290 | 119,772 (0%) | 0% | 113.2 | 259,228 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Sale of securities on an exchange or to another person at price $ 117.66 per share. | 06 Feb 2026 | 13,000 | 122,062 (0%) | 0% | 117.7 | 1,529,645 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.75 per share. | 10 Nov 2025 | 4,668 | 135,021 (0%) | 0% | 38.8 | 180,908 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 4,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.24 per share. | 23 Sep 2025 | 33 | 339 (0%) | 0% | 108.2 | 3,572 | Common Stock |
| Trupanion Inc | Max K. Broden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 4,239 | 4,239 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Max K. Broden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 1,630 | 1,630 | - | - | Restricted Stock Unit (RSU) | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 53,583 | 152,765 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 22,535 | 130,230 (0%) | 0% | 102.6 | 2,312,316 | Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 78 | 380 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.33 per share. | 11 Feb 2025 | 12 | 368 (0%) | 0% | 103.3 | 1,240 | Common Stock |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,582 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,582 | 8,571 (0%) | 0% | 0 | Common Stock | |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,581 | 1,582 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,581 | 6,989 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.03 per share. | 23 Sep 2024 | 32 | 301 (0%) | 0% | 110.0 | 3,521 | Common Stock |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,581 | 3,163 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,581 | 5,408 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.54 per share. | 29 Apr 2024 | 8,894 | 99,073 (0%) | 0% | 84.5 | 751,899 | Common Stock |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 1,582 | 3,827 (0%) | 0% | 0 | Common Stock | |
| Trupanion Inc | Max K. Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 1,582 | 4,744 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Max K. Broden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 6,326 | 6,326 | - | - | Restricted Stock Unit (RSU) | |
| Aflac Inc | K. Max Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 56,907 | 131,432 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.23 per share. | 15 Feb 2024 | 23,632 | 107,800 (0%) | 0% | 78.2 | 1,848,731 | Common Stock |
| Trupanion Inc | K. Max Broden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 1,141 | 2,245 (0%) | 0% | 0 | Common Stock | |
| Trupanion Inc | Max Broden K. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 1,141 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 31,721 | 86,135 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.01 per share. | 13 Feb 2023 | 12,232 | 73,903 (0%) | 0% | 71.0 | 868,594 | Common Stock |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 7,181 | 54,414 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 260 | 260 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 94 | 330 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.31 per share. | 23 Sep 2022 | 32 | 235 (0%) | 0% | 76.3 | 2,442 | Common Stock |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 18,564 | 55,618 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc | Max K. Broden | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.22 per share. | 14 Feb 2022 | 8,873 | 46,745 (0%) | 0% | 64.2 | 569,824 | Common Stock |